{"status":"OK","data":{"advertisement":{"id":365323,"title":"INC/8/PR153521/ 2026-106897-276538\n zakup i dostawa opakowa\u0144 bezpo\u015brednich do pr\u00f3b technologicznych\n\nINC/8/PR153521/ 2026-106897-276538\n the purchase and delivery of direct packaging for technological trials","partial_offer_allowed":false,"publication_date":"2026-05-07","submission_deadline":"2026-05-14 23:59:59","planned_sign_date":"2026-05-01","supplementary_orders":"14.7.\tZamawiaj\u0105cy zastrzega sobie prawo do udzielenia Wykonawcy zam\u00f3wie\u0144 dodatkowych, nie obj\u0119tych przedmiotem zam\u00f3wienia podstawowego, je\u015bli zmiany dotycz\u0105 realizacji dodatkowych dostaw, us\u0142ug lub rob\u00f3t budowlanych od dotychczasowego wykonawcy, nieobj\u0119tych zam\u00f3wieniem podstawowym, o ile sta\u0142y si\u0119 niezb\u0119dne i zosta\u0142y spe\u0142nione \u0142\u0105cznie nast\u0119puj\u0105ce warunki:\ni) zmiana wykonawcy nie mo\u017ce zosta\u0107 dokonana z powod\u00f3w ekonomicznych lub technicznych, w szczeg\u00f3lno\u015bci dotycz\u0105cych zamienno\u015bci lub interoperacyjno\u015bci sprz\u0119tu, us\u0142ug lub instalacji, zam\u00f3wionych w ramach zam\u00f3wienia podstawowego,\nii) zmiana wykonawcy spowodowa\u0142aby istotn\u0105 niedogodno\u015b\u0107 lub znaczne zwi\u0119kszenie koszt\u00f3w dla zamawiaj\u0105cego,\niii) warto\u015b\u0107 zmian nie przekracza 50% warto\u015bci zam\u00f3wienia okre\u015blonej pierwotnie w umowie, \n14.7.\tThe Contracting Authority reserves the right to award the Contractor additional contracts, not covered by the subject matter of the basic contract, if the changes concern the performance of additional supplies, services or construction works from the existing contractor, not covered by the basic contract, provided that they have become necessary and the following conditions have been met:\ni) the change of contractor cannot be made for economic or technical reasons, in particular those related to the interchangeability or interoperability of equipment, services or installations ordered under the basic contract,\nii) a change of contractor would cause a significant inconvenience or a significant increase in costs for the contracting authority,\niii) the value of the changes does not exceed 50% of the value of the contract originally specified in the contract,","terms_of_contract_change":"w za\u0142\u0105czonych dokumentach\nFind in attached file","created_at":"2026-05-07 09:42:07","modified_at":"2026-05-15 00:00:35","contact_persons":[{"id":108239,"forename":"Marta","surname":"Patek","phone_number":"","email":"proces.ofertowy@polpharma.com","created_by":null,"created_at":"2026-08-13 08:02:36","modified_at":"2026-08-13 08:02:36","modified_by":null}],"orders":[{"id":590891,"estimated_value":null,"order_items":[{"id":664976,"description":"3.3.\tPrzedmiotem zam\u00f3wienia jest zakup i dostawa opakowa\u0144 bezpo\u015brednich do pr\u00f3b technologicznych. Przedmiot zam\u00f3wienia obejmuje: zakup i dostaw\u0119 ampu\u0142kostrzykawek do pr\u00f3b technologicznych oraz wytwarzania, kt\u00f3re b\u0119dzie realizowane przy u\u017cyciu farmaceutycznej linii rozlewu pracuj\u0105cej w warunkach kontrolowanych parametr\u00f3w \u015brodowiskowych zgodnie z wymaganiami GMP.\n3.4.\t Zakres zapytania ofertowego obejmuje ampu\u0142kostrzykawki o obj\u0119to\u015bci 2,25 mL w ilo\u015bci 141 000 sztuk. Zamawiaj\u0105cy dopuszcza sk\u0142adanie ofert na ilo\u015bci wynikaj\u0105ce z minimalnych wielko\u015bci opakowa\u0144 stosowanych przez wykonawc\u0119, pod warunkiem \u017ce oferowana ilo\u015b\u0107 mie\u015bci si\u0119 w przedziale od 141 000 do 160 000 sztuk.\u201d\n\u2022\twykonane z bezbarwnego szk\u0142a borokrzemianowego, klasa hydrolityczna I (zgodnie z EP 3.2.1 i USP 660), z okr\u0105g\u0142ym ko\u0142nierzem\n\u2022\tig\u0142a ze stali nierdzewnej 304 o wymiarach 27g; \u00bd cala, 5 skos\u00f3w (wersja o cienkich \u015bciankach)\n\u2022\tsztywna nasadka na ig\u0142\u0119: cz\u0119\u015b\u0107 wewn\u0119trzna wykonana z szarej gumy poliizoprenowej (zgodnie z EP 3.2.9), cz\u0119\u015b\u0107 zewn\u0119trzna wykonana z transparentnego polipropylenu (zgodnie z EP 3.2.9 i USP 381)\n\u2022\tsilanizowanie przy u\u017cyciu Liveo Medical Fluid 360 (zgodnie z EP 3.1.8 i USP <Dimethicone>): strzykawka (silanizowanie p\u0142ynem o lepko\u015bci 1000 cSt), ig\u0142a (silanizowanie p\u0142ynem o lepko\u015bci 12500 cSt)\n\u2022\tsystem pakowania nest (polipropylen) and tub (polistyren); po 100 ampu\u0142kostrzykawek. Pozosta\u0142e elementy opakowania (sheet i lid) wykonane z materia\u0142u Tyvek. Ca\u0142o\u015b\u0107 spakowana w podw\u00f3jny worek\n\u2022\tampu\u0142kostrzykawki w formie gotowej do u\u017cycia, wysterylizowane przy u\u017cyciu tlenku etylenu (sterylno\u015b\u0107 zgodnie z EP 2.6.1, poziom obci\u0105\u017cenia mikrobiologicznego zgodnie z EP 2.6.12, poziom endotoksyn zgodnie z EP 2.6.14)\n\u2022\tbadanie zanieczyszczenia cz\u0105stkami niewidocznymi okiem nieuzbrojonym zgodnie z EP 2.9.19\n\u2022\ttesty funkcjonalne (zgodnie z ISO 11040-4):\n\uf0d8\tbreak-loose force: \u2264 10 N\n\uf0d8\tgliding force: \u2264 5 N\n\uf0d8\tclosure pull off force: \u2265 4 N i \u2264 35 n\n\uf0d8\tneedle pull out force: \u2265 22 N\n\uf0d8\tflange breakage resistance: > 50 N\n3.5.\tOkres przydatno\u015bci do u\u017cycia ampu\u0142kostrzykawek w momencie dostarczenia, nie mo\u017ce by\u0107 kr\u00f3tszy ni\u017c 12 miesi\u0119cy, przy czym deklarowany termin wa\u017cno\u015bci licz\u0105c od momentu wysterylizowania powinien wynosi\u0107 2 lata.\n5.1.\tTermin realizacji zam\u00f3wienia: do 31.12.2026 r.\nWi\u0119cej informacji w za\u0142\u0105cznikach\n\n3.3.\tThe subject of the contract is the purchase and delivery of direct packaging for technological trials. The subject of the contract includes: purchase and delivery of pre-filled syringes for technological trials and production, which will be carried out using a pharmaceutical filling line operating under controlled environmental parameters in accordance with GMP requirements.\n3.4.\t The scope of the request for proposal includes 2.25 mL pre-filled syringes in the amount of 141,000 pieces. The Contracting Authority permits the submission of bids for quantities resulting from the minimum packaging sizes used by the Contractor, provided that the quantity offered is in the range of 141,000 to 160,000 pieces.\"\n\u2022\tmade of clear borosilicate glass, hydrolytic class I (according to EP 3.2.1 and USP 660), with a round flange\n\u2022\t304 stainless steel needle 27G; 1/2 inch, 5 bevels (thin-walled version)\n\u2022\trigid needle shield: inner part made of grey polyisoprene rubber (according to EP 3.2.9), outer part made of transparent polypropylene (according to EP 3.2.9 and USP 381)\n\u2022\tsilanizing with Liveo Medical Fluid 360 (according to EP 3.1.8 and USP <Dimethicone>): syringe (silanizing with 1000 cSt viscosity liquid), needle (silanizing with 12500 cSt viscosity liquid)\n\u2022\tNest (polypropylene) and tub (polystyrene) packaging system; 100 pre-filled syringes each. Other packaging elements (sheet and lid) are made of Tyvek material. The whole nest and tub is packed in a double bag\n\u2022\tready-to-use pre-filled syringes, sterilised with ethylene oxide (sterility according to EP 2.6.1, microbial bioburden level according to EP 2.6.12, endotoxin level according to EP 2.6.14)\n\u2022\tTesting for microscopic particle count according to EP 2.9.19\n\u2022\tFunctional tests (according to ISO 11040-4):\n\uf0d8\tbreak-loose force: \u2264 10 N\n\uf0d8\tgliding force: \u2264 5 N\n\uf0d8\tclosure pull off force: \u2265 4 N and \u2264 35 N\n\uf0d8\tneedle pull out force: \u2265 22 N\n\uf0d8\tflange breakage resistance: > 50 N\n3.5.\tThe shelf life of pre-filled syringes at the time of delivery must not be less than 12 months, while the declared shelf life from the moment of sterilization should be 2 years.\n5.1.\tOrder delivery  date: by 31.12.2026\nPlease find more information in the attached file","warranty_period":null,"cpv_items":[{"id":2811,"code":"33141310-6","name":"Strzykawki"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":"2026-05-07 09:42:07","modified_at":"2026-05-07 12:51:40","modified_by":null,"id":756721,"type":{"id":1,"name":"adres"},"group_uuid":"c1d731b5-04f8-4df8-a77d-6887f04539dc"}],"participation_conditions":[{"id":1899634,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje uprawnieniami niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia.\nSpos\u00f3b oceny warunku:\nZamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca z\u0142o\u017cy \no\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 1 do Zapytania \nOfertowego). Zamawiaj\u0105cy zastrzega mo\u017cliwo\u015b\u0107 wezwania Wykonawcy do dostarczenia \ndokument\u00f3w potwierdzaj\u0105cych spe\u0142nienie tego warunku.\n\nthe right to perform a specific activity or activity \nThe Contracting Authority shall consider that the Bidder meets this condition if it submits a declaration that it has the rights necessary for the proper performance of the contract.\nMethod of assessment of the condition:\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor submits a statement on the fulfilment of the conditions for participation in the procedure (Appendix No. 1)\nOffer Agreement). The Contracting Authority reserves the right to call upon the Contractor to deliver documents confirming that this condition is met.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2026-05-07 10:11:52","modified_at":"2026-05-07 12:51:40","modified_by":null,"group_uuid":"3defad8b-3f4c-4ca9-8f80-1bcec820bcde"},{"id":1899635,"description":"6.1.2.\tsytuacji ekonomicznej lub finansowej\nZamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, w szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.\nSpos\u00f3b oceny warunku:\nZamawiaj\u0105cy uzna, \u017ce Wykonawca spe\u0142nia niniejszy warunek, je\u017celi Wykonawca z\u0142o\u017cy \no\u015bwiadczenie o spe\u0142nieniu warunk\u00f3w udzia\u0142u w post\u0119powaniu (Za\u0142\u0105cznik nr 1 do Zapytania \nOfertowego). Zamawiaj\u0105cego zastrzega mo\u017cliwo\u015b\u0107 wezwania Wykonawcy do dostarczenia \ndokument\u00f3w potwierdzaj\u0105cych spe\u0142nienie tego warunku.\n\neconomic or financial situation\nThe Contracting Authority shall consider that the Tenderer meets this condition if it submits a declaration that it is in an economic and financial situation ensuring the proper performance of the contract, in particular it is not in a state of bankruptcy, restructuring or liquidation.\nMethod of assessment of the condition:\nThe Contracting Authority shall consider that the Contractor meets this condition if the Contractor submits \na statement on the fulfilment of the conditions for participation in the procedure (Appendix No. 1). The Contracting Authority reserves the right to call on the Contractor to provide \ndocuments confirming that this condition is met.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-05-07 10:11:52","modified_at":"2026-05-07 12:51:40","modified_by":null,"group_uuid":"fbc8be47-aba5-4f91-b90f-08de074313b7"},{"id":1899636,"description":"6.2.\tPrzes\u0142anki wykluczenia\n6.2.1.\tZ udzia\u0142u w post\u0119powaniu wykluczone s\u0105 podmioty powi\u0105zane osobowo lub kapita\u0142owo \nz Zamawiaj\u0105cym.\nPrzez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy Zamawiaj\u0105cym lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu Zamawiaj\u0105cego, lub osobami wykonuj\u0105cymi w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zane z przygotowaniem i przeprowadzaniem procedury wyboru wykonawcy a Oferentem, polegaj\u0105ce w szczeg\u00f3lno\u015bci na:\na)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej,\nb)\tposiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji, o ile ni\u017cszy pr\u00f3g nie wynika z przepis\u00f3w prawa,\nc)\tpe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika,\nd)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa w linii prostej, pokrewie\u0144stwa lub powinowactwa w linii bocznej do drugiego stopnia lub zwi\u0105zaniu z tytu\u0142u przysposobienia, opieki lub kurateli,\ne)\tpozostawaniu we wsp\u00f3lnym po\u017cyciu z Oferentem, jego zast\u0119pc\u0105 prawnym lub cz\u0142onkami organ\u00f3w zarz\u0105dzaj\u0105cych lub organ\u00f3w nadzorczych Oferent\u00f3w ubiegaj\u0105cych si\u0119 o udzielenie zam\u00f3wienia,\nf)\tpozostawaniu z Oferentem w takim stosunku prawnym lub faktycznym, \u017ce istnieje uzasadniona w\u0105tpliwo\u015b\u0107 co do bezstronno\u015bci lub niezale\u017cno\u015bci w zwi\u0105zku z post\u0119powaniem o udzielenie zam\u00f3wienia.\n\nSpos\u00f3b weryfikacji podstaw/braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi na podstawie o\u015bwiadczenia Oferenta oraz o\u015bwiadcze\u0144 Zamawiaj\u0105cego i os\u00f3b wykonuj\u0105cych w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zanych z przygotowaniem i przeprowadzaniem procedury wyboru wykonawcy.\n\n6.2.2 Z udzia\u0142u w post\u0119powaniu wykluczone s\u0105 r\u00f3wnie\u017c podmioty, w stosunku do kt\u00f3rych zachodz\u0105 okoliczno\u015bci:\na)\tw art. 7 ust. 1 ustawy z dnia 13 kwietnia 2022 r. o szczeg\u00f3lnych rozwi\u0105zaniach w zakresie przeciwdzia\u0142ania wspieraniu agresji na Ukrain\u0119 oraz s\u0142u\u017c\u0105cych ochronie bezpiecze\u0144stwa narodowego (Dz.U. z 2024 r., Poz. 507 t.j. z p\u00f3\u017an. zm.);\nb)\tw art. 5k Rozporz\u0105dzenia Rady (UE) nr 833/2014 z dnia 31 lipca 2014 r. dotycz\u0105cego \u015brodk\u00f3w ograniczaj\u0105cych w zwi\u0105zku z dzia\u0142aniami Rosji destabilizuj\u0105cymi sytuacj\u0119 na Ukrainie (Dz. Urz. UE nr L 229 z 31.07.2014, str. 1), w brzmieniu nadanym Rozporz\u0105dzeniem Rady (UE) nr 2022/576 w sprawie zmiany rozporz\u0105dzenia (UE) nr 833/2014 dotycz\u0105cego \u015brodk\u00f3w ograniczaj\u0105cych w zwi\u0105zku z dzia\u0142aniami Rosji destabilizuj\u0105cymi sytuacj\u0119 na Ukrainie (Dz. Urz. UE nr L 111 z 8.04.2022, str. 1, z p\u00f3\u017an. zm.);\nSpos\u00f3b weryfikacji podstaw/braku podstaw wykluczenia:\nWeryfikacja nast\u0105pi na podstawie o\u015bwiadczenia Oferenta.\n\n6.3.\tOferty z\u0142o\u017cone przez podmioty, kt\u00f3re nie spe\u0142niaj\u0105 warunk\u00f3w udzia\u0142u w post\u0119powaniu b\u0105d\u017a w stosunku do kt\u00f3rych zachodz\u0105 przes\u0142anki do wykluczenia z udzia\u0142u w post\u0119powaniu, podlegaj\u0105 odrzuceniu i nie b\u0119d\u0105 oceniane.\n6.2.\tGrounds for exclusion\n6.2.1.\tEntities related to the Ordering Party in \nterms of personal or capital are excluded from participation in the procedure.\nCapital or personal ties shall be understood as mutual links between the Ordering Party or persons authorised to incur obligations on behalf of the Contracting Authority, or persons performing on behalf of the Contracting Authority activities related to the preparation and conduct of the contractor selection procedure and the Bidder, consisting in particular in:\na)\tparticipation in the company as a partner in a civil partnership or partnership,\nb)\tholding at least 10% of shares or stocks, unless a lower threshold results from the provisions of law,\nc)\tperforming the function of a member of a supervisory or management body, proxy, proxy,\nd)\tbeing married, in a relationship of kinship or affinity in the direct line, kinship or affinity in the collateral line to the second degree, or being connected by adoption, guardianship or guardianship,\ne)\tcohabitation with the Bidder, its legal representative or members of the management or supervisory bodies of the Bidders applying for the award of the contract,\nf)\tremaining in such a legal or factual relationship with the Tenderer that there is a reasonable doubt as to impartiality or independence in connection with the procurement procedure.\n\nMethod of verifying the grounds/absence of grounds for exclusion:\nThe verification will take place on the basis of the Bidder's statement and the statements of the Contracting Authority and persons performing activities related to the preparation and implementation of the contractor selection procedure on behalf of the Contracting Authority.\n\n6.2.2 Entities in relation to which the following circumstances occur are also excluded from participation in the proceedings:\na)\tArticle 7(1) of the Act of 13 April 2022 on special solutions for counteracting support for aggression against Ukraine and for the protection of national security (Journal of Laws of 2024, item 507, as amended);\nb)\tArticle 5k of Council Regulation (EU) No 833/2014 of 31 July 2014 concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (Official Journal of the European Union). EU No L 229 of 31.07.2014, p. 1), as amended by Council Regulation (EU) No 2022/576 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia's actions destabilising the situation in Ukraine (OJ L 222, p. OJ L 111 of 8.04.2022, p. 1, as amended. as amended);\nMethod of verifying the grounds/absence of grounds for exclusion:\nThe verification will take place on the basis of the Bidder's statement.\n\n6.3.\tBids submitted by entities that do not meet the conditions for participation in the procedure or for which there are grounds for exclusion from participation in the procedure are subject to rejection and will not be evaluated.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-05-07 10:11:52","modified_at":"2026-05-07 12:51:40","modified_by":null,"group_uuid":"cf7d1a11-4e11-43b2-b8ab-6e7026bde630"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2026-05-07 09:42:07","modified_at":"2026-05-07 12:51:40","modified_by":null,"group_uuid":"b4f93759-b9d4-439c-aac3-fcd5c991ba40"}],"evaluation_criteria":[{"id":1064167,"price_criterion":true,"description":"8.1.\tPrzy ocenianiu ofert Zamawiaj\u0105cy b\u0119dzie kierowa\u0142 si\u0119 podanymi kryteriami: \n-\tCena \u2013 100%, \nWi\u0119cej informacji w za\u0142\u0105czonych dokumentach\n8.1.\tWhen evaluating the bids, the Contracting Authority will be guided by the following criteria: \n-\tPrice \u2013 100%, \n more informaction in attached file","created_by":null,"created_at":"2026-05-07 10:21:29","modified_at":"2026-05-07 12:51:40","modified_by":null,"group_uuid":"a813c10a-45db-41f1-ab0e-942e1a618746"}],"is_variant":false,"title":"zakup i dostawa opakowa\u0144 bezpo\u015brednich do pr\u00f3b techn.","order_node":{"id":446405},"created_by":null,"created_at":"2026-05-07 09:42:07","modified_at":"2026-05-07 12:51:40","modified_by":null}],"created_by":{"id":106897,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Zak\u0142ady Farmaceutyczne Polpharma SA","identification_number_type":"nip","identification_number":"5920202822","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":1030690,"street":"Pelpli\u0144ska ","number_description":"19","postcode":"83-200"},"created_by":{"id":106897,"contact_persons":[]},"created_at":"2026-05-07 09:42:07","modified_at":"2026-05-07 09:42:07","modified_by":{"id":106897,"contact_persons":[]},"id":366324},"advertisement":{"id":276538,"number":"2026-106897-276538","publication_date":"2026-05-07","created_by":{"id":106897,"contact_persons":[]},"created_at":"2026-05-07 09:42:07","modified_at":"2026-05-15 00:00:35","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[365323],"enrollment":null,"projects":[{"id":65683,"name":"Opracowanie innowacyjnej platformy technologiczno - analitycznej do produkcji lek\u00f3w zawieraj\u0105cych oligonukleotydy w formie gotowej do u\u017cycia.","number":"0007/25","activity":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 10:03:17","modified_at":"2025-08-12 10:03:17","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"region":null,"institution":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 11:06:27","modified_at":"2025-08-12 11:06:27","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"full_number":"FENG.05.01-IP.01-0007/25","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-08-12 10:02:53","modified_at":"2025-08-12 10:02:53","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"type":"project","created_by":{"id":106897,"contact_persons":[]},"created_at":"2025-10-30 08:48:53","modified_at":"2025-10-30 08:48:53","modified_by":{"id":106897,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":365323,"publication_date":"2026-05-07"},"id":2512124,"name":"zapytanie ofertowe","file":{"id":2788704,"name":"pol_INC 8  .pdf","created_at":"2026-05-07 12:44:24","created_by":{"forename":"Marta","surname":"Patek"},"uri":"/api/files/2788704"},"group_uuid":"860c87b8-b9cd-495a-a441-992a8f9f209a"},{"origin":{"id":365323,"publication_date":"2026-05-07"},"id":2512125,"name":"english version -request for proposal","file":{"id":2788707,"name":"en_INC 8 .pdf","created_at":"2026-05-07 12:44:41","created_by":{"forename":"Marta","surname":"Patek"},"uri":"/api/files/2788707"},"group_uuid":"e0e328dd-e29d-4389-a8ad-6a550b9ad145"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}